| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.85.12.1179 |
| P698 | PubMed publication ID | 10590245 |
| P50 | author | Richard D Kenagy | Q57747989 |
| P2093 | author name string | D F Bowen-Pope | |
| R A Seifert | |||
| A W Clowes | |||
| D P Mason | |||
| D Hasenstab | |||
| S Coats | |||
| S M Hawkins | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell migration | Q189092 |
| P304 | page(s) | 1179-1185 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery | |
| P478 | volume | 85 |
| Q58864034 | Acute and chronic phagocyte determinants of cardiac allograft vasculopathy |
| Q35832106 | Angiogenic transforming capacity of IgG purified from plasma of type 1 diabetic patients |
| Q91811810 | Anti-Atherosclerotic Effect of Hibiscus Leaf Polyphenols against Tumor Necrosis Factor-alpha-Induced Abnormal Vascular Smooth Muscle Cell Migration and Proliferation |
| Q35010277 | Attenuation of chondrogenic transformation in vascular smooth muscle by dietary quercetin in the MGP-deficient mouse model |
| Q39052677 | Berberine suppresses in vitro migration of human aortic smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF-κB. |
| Q37762507 | Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. |
| Q74354777 | C-terminal fragment of alpha1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor |
| Q24799866 | CCN5 modulates the antiproliferative effect of heparin and regulates cell motility in vascular smooth muscle cells |
| Q42696941 | Crucial role of HSP90 in the Akt-dependent promotion of angiogenic-like effect of glucose-regulated protein94 (Grp94)-IgG complexes. |
| Q38497884 | Deoxypodophyllotoxin, flavolignan, from Anthriscus sylvestris Hoffm. inhibits migration and MMP-9 via MAPK pathways in TNF-alpha-induced HASMC. |
| Q35748102 | Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: response to soluble and extracellular matrix-bound tumor necrosis factor-alpha |
| Q36700048 | Dysfunction in elastic fiber formation in fibulin-5 null mice abrogates the evolution in mechanical response of carotid arteries during maturation |
| Q24616455 | EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment |
| Q39277240 | Effect of Rosemarinus officinalis L. on MMP-9, MCP-1 levels, and cell migration in RAW 264.7 and smooth muscle cells |
| Q44187062 | Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia |
| Q36802414 | Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke |
| Q35068725 | Essential oils purified from Schisandrae semen inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 activation and migration of human aortic smooth muscle cells |
| Q42018678 | Evaluation of recombinant endostatin in the treatment of atherosclerotic plaques and neovascularization in rabbits |
| Q47609299 | Gastrin-releasing peptide promotes the migration of vascular smooth muscle cells through upregulation of matrix metalloproteinase-2 and -9. |
| Q41864365 | Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery |
| Q47937206 | Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease |
| Q36087889 | Herbal composition of Cinnamomum cassia, Pinus densiflora, Curcuma longa and Glycyrrhiza glabra prevents atherosclerosis by upregulating p27 (Kip1) expression |
| Q35479993 | Hypertensive vascular remodeling was inhibited by Xuezhikang through the regulation of Fibulin-3 and MMPs in spontaneously hypertensive rats |
| Q92867012 | Identification and validation of four hub genes involved in the plaque deterioration of atherosclerosis |
| Q53173174 | Impaired SIRT1 promotes the migration of vascular smooth muscle cell-derived foam cells. |
| Q38519525 | In vitro cellular aging is associated with enhanced proliferative capacity, G1 cell cycle modulation, and matrix metalloproteinase-9 regulation in mouse aortic smooth muscle cells |
| Q37444646 | In vivo measurement of hemodynamic information in stenosed rat blood vessels using X-ray PIV. |
| Q34075485 | Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth |
| Q55343968 | Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits. |
| Q50450346 | Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury. |
| Q53823068 | Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice. |
| Q45068673 | Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-alpha through inhibition of matrix metalloproteinase-2 and -9 activity |
| Q53601919 | Inhibitory effect of Salvia miltiorrhia BGE on matrix metalloproteinase-9 activity and migration of TNF-alpha-induced human aortic smooth muscle cells. |
| Q45964348 | Interleukin-6 upregulates expression of KDR and stimulates proliferation of human cerebrovascular smooth muscle cells. |
| Q33502837 | Intravital molecular imaging of small-diameter tissue-engineered vascular grafts in mice: a feasibility study |
| Q90441934 | Leptin upregulates smooth muscle cell expression of MMP-9 to promote plaque destabilization by activating AP-1 via the leptin receptor/MAPK/ERK signaling pathways |
| Q34405713 | MMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9. |
| Q36402867 | MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. |
| Q34420376 | Matrix Metalloproteinase Activation Predicts Amelioration of Remodeling After Dietary Modification in Injured Arteries |
| Q46105816 | Matrix metalloproteinase suppression induced by clarithromycin in murine cardiac allografts |
| Q35692009 | Matrix metalloproteinases and atherosclerosis |
| Q42552403 | Matrix metalloproteinases modulated by protein kinase Cε mediate resistin-induced migration of human coronary artery smooth muscle cells |
| Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
| Q36026069 | Mechanisms involved in the association between periodontal diseases and cardiovascular disease |
| Q36404987 | Mechanisms of post-intervention arterial remodelling |
| Q53979803 | Mechanisms of reduced human vascular cell migration after photodynamic therapy. |
| Q35574168 | Metalloproteinases and plasminogen activators in vessel remodeling |
| Q30485880 | Molecular imaging of activated matrix metalloproteinases in vascular remodeling |
| Q34146262 | Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering |
| Q37528238 | Nanoparticle-mediated arresten gene inhibits neointimal formation of vein grafts: an experimental research |
| Q37179695 | Novel therapies for cyclic GMP control of vascular smooth muscle growth |
| Q35766044 | Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration |
| Q26781838 | Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques |
| Q28578929 | PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation |
| Q41347813 | Patterns of gelatinase activation induced by injury in the murine femoral artery |
| Q34096205 | Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases |
| Q38521084 | Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. |
| Q44437894 | Rapamycin inhibits vascular remodeling in an experimental model of allograft vasculopathy and attenuates associated changes in fibrosis-associated gene expression |
| Q36328263 | Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. |
| Q34107565 | Regulation of cell migration in atherosclerosis |
| Q38969474 | Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness |
| Q47337393 | Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina. A preliminary study |
| Q28118787 | SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis |
| Q64378343 | Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery |
| Q36055619 | The adventitia: a dynamic interface containing resident progenitor cells. |
| Q37946664 | The adventitia: a progenitor cell niche for the vessel wall |
| Q35156068 | The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones |
| Q34022649 | The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease |
| Q36564604 | The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. |
| Q26864987 | The role of oxidative stress and inflammation in cardiovascular aging |
| Q34107537 | The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies |
| Q88920980 | Vascular Permeability and Remodelling Coincide with Inflammatory and Reparative Processes after Joint Bleeding in Factor VIII-Deficient Mice |
| Q50975516 | Vascular smooth muscle cell differentiation to an osteogenic phenotype involves matrix metalloproteinase-2 modulation by homocysteine. |
| Q41820104 | u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer |
Search more.